Cardiovascular and metabolic alterations in mice lacking β1- and β2-adrenergic receptors

Trends in Cardiovascular Medicine

Volumn 12, Issue 7, 2002, Pages 287-294

  Bernstein, Daniel ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; BLOOD VESSEL TONE; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; CHRONOTROPISM; EXERCISE; GENE; HEART DEVELOPMENT; INOTROPISM; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS;

NON-PROGRAMMATIC;

ANIMALS; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; EXERCISE; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SYMPATHETIC NERVOUS SYSTEM;

EID: 0036811153     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00176-7     Document Type: Review

References (50)

1. Bishopric N., Sato B., Webster K. β-adrenergic regulation of a myocardial actin gene via a cyclic AMP-independent pathway. J Biol Chem. 267:1992;20,932-20,936.
2. Bisognano J., Weinberger H., Bohlmeyer T.et al. Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 32:2000;817-830.
3. Bristow J., Hersherger R., Port J.et al. β1- and β2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 35:1989;295-303.
4. Bristow M., Ginsburg R., Umans V.et al. β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium. coupling of both receptor subtypes to muscle contraction and selective down-regulation in heart failure Circ Res. 59:1986;297-309.
5. Bristow M.R., Gilbert E.M., Abraham W.T.et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators [comment]. Circulation. 94:1996;2807-2816.
6. Brodde O. β1 and β2-adrenoceptors in the human heart. properties, function, and alterations in chronic heart failure Pharmacol Rev. 43:1991;203-242.
7. Cheng H.J., Zhang Z.S., Onishi K.et al. Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ Res. 89:2001;599-606.
8. Chruscinski A.J., Rohrer D.K., Schauble E.et al. Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem. 274:1999;16,694-16,700.
9. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 98:1998;1329-1334.
10. Daaka Y., Luttrell L., Lefkowitz R. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
11. Desai D., Rohrer D., Kobilka B., Bernstein D. Diminished contractile response to isoproterenol in beta-1 adrenergic receptor deficient mice. Circulation. 94:1996;1-288.
12. Desai K., Sato R., Schauble E.et al. Cardiovascular indexes in the mouse at rest and with exercise. new tools to study models of cardiac disease Am J Physiol. 272:1997;H1053-H1061.
13. Devic E., Xiang Y., Gould D., Kobilka B. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol. 60:2001;577-583.
14. Dixon R.A., Kobilka B.K., Strader D.J.et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature. 321:1986;75-79.
15. Emorine L.J., Marullo S., Briend-Sutren M.et al. Molecular characterization of the human beta 3-adrenergic receptor. Science. 245:1989;1118-1121.
16. Engelhardt S., Hein L., Wisemann F., Lohse M. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA. 96:1999;7059-7064.
17. Frielle T., Collins S., Daniel K.et al. Cloning of the cDNA for the human β1-adrenergic receptor. Proc Natl Acad Sci USA. 84:1987;7920-7924.
18. Gauthier C., Leblais V., Kobzik L.et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 102:1998;1377-1384.
19. Gauthier C., Tavernier G., Charpentier F.et al. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 98:1996;556-562.
20. Gauthier C., Tavernier G., Trochu J.et al. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther. 290:1999;687-693.
21. Hoit B.D., Khoury S.F., Kranias E.G.et al. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 77:1995;632-637.
22. Hoit B., Walsh E. Cardiovascular Physiology in the Genetically Engineered Mouse. 1998;Kluwer Academic Publishers, Boston.
23. Iwai-Kanai E., Hasegawa K., Araki M.et al. Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation. 100:1999;305-311.
24. Iwaki K., Sukhatme V., Shubeita H., Chien K. α and β-adrenergic stimulation induce distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem. 265:1990;13,809-13,817.
25. Klug S., Thiel R., Schwabe R.et al. Toxicity of beta-blockers in a rat whole embryo culture. concentration-response relationships and tissue concentrations Arch Toxicol. 68:1994;375-384.
26. Koch W., Rockman H., Samama P.et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 268:1995;1350-1353.
27. Kohout T.A., Takaoka H., McDonald P.H.et al. Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation. 104:2001;2485-2491.
28. Kuznetsov V., Pak E., Robinson R.B., Steinberg S.F. β2-Adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res. 76:1995;40-52.
29. Liggett S., Tepe N., Lorenz J.et al. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts. Critical role for expression level. Circulation. 101:2000;1707-1714.
30. Long C., Hartogensis W., Simpson P. β-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J Mol Cell Cardiol. 25:1993;915-925.
31. Luttrell L., Gerguson S., Daaka Y.et al. β-arrestin-dependent formation of β2-adrenergic receptor-Src protein kinase complexes. Science. 283:1999;655-661.
32. McDonald P., Chow C.-W., Miller W.et al. β-arrestin 2. a receptor-regulated MAPK scaffold for the activation of JNK3 Science. 290:2000;1574-1577.
33. Milano C., Allen L., Rockman H.et al. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science. 264:1994;582-586.
34. Oostendorp J., Kaumann A.J. Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta1- and putative beta4- adrenoceptors in mouse left atria. no evidence for beta2- and beta3-adrenoreceptor function Naunyn Schmiedebergs Arch Pharmacol. 361:2000;134-145.
35. Post G., Goldstein D., Thuerauf D.et al. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem. 271:1996;8452-8457.
36. Rohrer D., Desai K., Jasper J.et al. Targeted disruption of the mouse β1-adrenergic receptor gene. developmental and cardiovascular effects Proc Natl Acad Sci USA. 93:1996;7375-7380.
37. Rohrer D., Schauble E., Desai K.et al. Alterations in dynamic heart rate control in the beta-1 adrenergic receptor knockout mouse. Am J Physiol. 43:1998;H1184-H1193.
38. Rohrer D.K., Chruscinski A., Schauble E.H.et al. Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem. 274:1999;16,701-16,708.
39. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 17:1985;291-306.
40. Sabri A., Pak E., Alcott S.A.et al. Coupling function of endogenous alpha(1)- and beta-adrenergic receptors in mouse cardiomyocytes. Circ Res. 86:2000;1047-1053.
41. Shen Y.T., Cervoni P., Claus T., Vatner S.F. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J Pharmacol Exp Ther. 278:1996;1435-1443.
42. Simpson P., Kariya K., Karns L.et al. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 104:1991;35-43.
43. Steinberg S.F. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res. 85:1999;1101-1111.
44. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G protein coupled receptors. FASEB J. 9:1995;745-754.
45. Susulic V.S., Fredericj R.C., Lawitts J.et al. Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem. 270:1995;29,483-29,492.
46. Vatner S., Farnklin D., Higgins C.et al. Left ventricular response to severe exertion in untethered dogs. J Clin Invest. 51:1972;3052-3060.
47. Xiao R.-P., Avdonin P., Zhou Y.-Y.et al. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res. 84:1999;43-52.
48. Xiao R.-P., Ji X., Lakatta E. Functional coupling of the β2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 47:1995;322-329.
49. ++ current in single rat ventricular cells. Circ Res. 73:1993;286-300.
50. Zhu W.Z., Zheng M., Koch W.J.et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA. 98:2001;1607-1612.